May 2024

Private Healthcare Devices Company

Private Healthcare Devices Company

Exclusive Financial Advisor to the Company on its Balance Sheet Recapitalization

Canaccord Genuity Acts as Exclusive Financial Advisor to a Private Healthcare Devices Company on its Balance Sheet Recapitalization

More Like This

Pending Completion

Neuronetics

Financial Advisor to Neuronetics on its Announced Merger with Greenbrook TMS
November 2024

UCB

Advisor to UCB on the Sale of the Rights of Nootropil® and Atarax® Products to Advanz Pharma
October 2024

Telemos Capital

Exclusive Financial Advisor (Buy side)

View all Healthcare transactions